- Tel: 858.663.9055
-
Email: info@nsjbio.com
- Tel: 858.663.9055
- Email: info@nsjbio.com
Legumain Antibody / Asparaginyl Endopeptidase Antibody detects LGMN, a lysosomal cysteine protease that specifically cleaves protein substrates after asparagine residues. Also known as AEP, Legumain belongs to the peptidase C13 family and functions in protein processing, lysosomal degradation pathways and regulation of cellular protease activity. This recombinant rabbit monoclonal antibody, clone 23L04, provides researchers with a tool for examining Legumain expression and localization in studies involving lysosomal biology, immune regulation and disease-associated protease activity.
Legumain is synthesized as an inactive precursor protein that undergoes proteolytic activation within acidic intracellular compartments such as lysosomes. Active asparaginyl endopeptidase participates in processing a variety of protein substrates and contributes to normal cellular protein turnover. Legumain has also been studied for its role in antigen processing, where lysosomal protease activity influences peptide generation and immune pathway regulation. Legumain Antibody is commonly used by researchers studying cysteine proteases, lysosome function, protein maturation and intracellular degradation pathways.
Research involving Legumain has demonstrated important connections between protease regulation, inflammation and cancer biology. Altered LGMN expression has been investigated in multiple tumor types, where this protease may contribute to extracellular matrix remodeling, tumor microenvironment interactions and cancer-associated cellular processes. Legumain expression has also been studied in immune cell populations, including macrophage-related research models, highlighting its relevance in both cancer and immunology studies.
As a member of the asparaginyl endopeptidase family, Legumain provides insight into how specialized proteases regulate cellular homeostasis and signaling environments. Detection of LGMN expression supports investigations into lysosomal pathways, protease activation mechanisms and biological systems where controlled protein cleavage is required. Recombinant rabbit monoclonal Legumain Antibody clone 23L04 enables analysis of this important cysteine protease across different experimental models.
Legumain Antibody applications include detection of LGMN expression, localization and regulation in biological samples using techniques such as Western blot, immunohistochemistry, immunofluorescence and related protein analysis methods. NSJ Bioreagents provides Legumain Antibody / Asparaginyl Endopeptidase Antibody, clone 23L04, for researchers studying lysosomal protease function, antigen processing, cancer biology and immune regulation pathways.
Legumain Antibody detects an asparaginyl endopeptidase involved in lysosomal protein processing, antigen regulation and tumor-associated protease activity, making it a useful marker for research areas featured in our Cell Biology Antibodies and Cancer Antibodies pages.
Optimal dilution of the Legumain Antibody / Asparaginyl Endopeptidase Antibody should be determined by the researcher.
A synthesized peptide derived from human LGMN protein was used as the immunogen for the Legumain Antibody.
Store the Legumain Antibody at -20oC for one year, or at 4oC for one month.
LGMN Antibody, AEP Antibody, Asparaginyl Endopeptidase Antibody, Cysteine Protease Legumain Antibody, Lysosomal Protease Antibody, Protease C13 Family Antibody
Your bulk quote request has been submitted successfully!
Please contact us if you have any questions.